MONEO: A phase II study of avelumab plus FLOT in the perioperative treatment for patients with resectable gastric or gastroesophageal junction cancer

被引：0

作者：

Alsina, M. ^{[1
,2
]}

Ponz-Sarvise, M. ^{[3
]}

Lopez Garcia, D. ^{[4
]}

Gonzalez, M. ^{[4
]}

De Andrea, C. ^{[5
]}

Gros, A. ^{[6
]}

Vivancos, A. ^{[7
]}

Jimenez Fonseca, P. ^{[8
]}

Diez, M. ^{[9
,10
]}

Arrazubi, V. ^{[11
]}

Sanz-Garcia, E. ^{[12
]}

Martinez de Castro, E. ^{[13
]}

Guardeno Sanchez, R. ^{[14
]}

Calvo Campos, M. ^{[15
]}

Buges Sanchez, C. ^{[16
]}

Munoz, F. ^{[17
]}

Tabernero, J. ^{[9
,10
]}

Villacampa, G. ^{[18
]}

Munoz, S. ^{[3
]}

Melero, I. ^{[19
]}

机构：

[1] Vall dHebron Inst Oncol VHIO Barcelona, Barcelona, Spain

[2] Complejo Hosp Navarra CHN Pamplona, Barcelona, Spain

[3] Clin Univ Navarra, Pamplona, Spain

[4] Vall dHebron Inst Oncol, CRS Unit, Barcelona, Spain

[5] Univ Navarra, Clin Univ Navarra, Ctr Invest Biomed Red Canc CIBERONC, Pamplona, Spain

[6] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Cellex Ctr, Tumor Immunol & Immunotherapy, Barcelona, Spain

[7] Vall dHebron Inst Oncol, Canc Genom Grp, Barcelona, Spain

[8] Hosp Univ Cent Asturias, ISPA, Oviedo, Spain

[9] Vall dHebron Univ Hosp, Barcelona, Spain

[10] Vall dHebron Inst Oncol, Barcelona, Spain

[11] Complejo Hosp Navarra, Pamplona, Spain

[12] HM Sanchinarro Ctr Integral Oncol Clara Campal, Madrid, Spain

[13] Hosp Univ Marques de Valdecilla, IDIVA, Santander, Spain

[14] Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain

[15] Inst Catala Oncol Hospitalet, ONCOBELL Program IDIBELL, Dept Med Oncol, Barcelona, Spain

[16] Germans Trias & Pujol Univ Hosp HUGTiP, Catalan Inst Oncol ICO Badalona, Dept Med Oncol, Badalona Appl Res Grp Oncol, Badalona, Spain

[17] Hosp Univ Ramon & Cajal, IRYCIS, CIBERONC, Madrid, Spain

[18] Vall dHebron Inst Oncol VHIO, Oncol Data Sci Grp, Barcelona, Spain

[19] Univ Navarra, Ctr Appl Med Res CIMA, Pamplona, Spain

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.05.219

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-164

引用

页码：S155 / S156

页数：2

共 50 条

[1] MONEO: Phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC)
Alsina, M.
Ponz-Sarvise, M.
Garcia, D. Lopez
Villacampa, G.
De Andrea, C.
Ochoa, C.
Lopez-Janeiro, A.
Jimenez-Fonseca, P.
Arrazubi, V.
Garcia, M. Diez
Sanz-Garcia, E.
de Castro, E. Martinez
Sanchez, R. Guardeno
Campos, M. Calvo
Sanchez, C. Buges
Longo, F.
Navarro, V.
Gros, A.
Vivancos, A.
Tabernero, J.
Munoz, S.
Melero, I.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S2 - S3
[2] MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC).
Alsina, Maria
Ponz-Sarvise, Mariano
Garcia, Dario Lopez
Gonzalez, Marta
De Andrea, Carlos E.
Gros, Alena
Vivancos, Ana
Jimenez-Fonseca, Paula
Garcia, Marc Diez
Arrazubi, Virginia
Sanz-Garcia, Enrique
de Castro, Eva Martinez
Guardeno, Raquel
Calvo, Mariona
Buges, Cristina
Longo, Federico
Tabernero, Josep
Villacampa, Guillermo
Munoz, Susana
Melero, Ignacio
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[3] MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
Janjigian, Yelena Y.
Van Cutsem, Eric
Muro, Kei
Wainberg, Zev
Al-Batran, Salah-Eddin
Hyung, Woo Jin
Molena, Daniela
Marcovitz, Michelle
Ruscica, Dario
Robbins, Scott H.
Negro, Alejandra
Tabernero, Josep
[J]. FUTURE ONCOLOGY, 2022, 18 (20) : 2465 - 2473
[4] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
Li, Hongli
Deng, Jingyu
Ge, Shaohua
Zang, Fenglin
Zhang, Le
Ren, Peng
Wang, Baogui
Cao, Fuliang
Deng, Ting
Liu, Rui
Ning, Tao
Yang, Yuchong
Bai, Ming
Wang, Xia
Ji, Zhi
Duan, Jingjing
Liu, Yong
Zhou, Dejun
Liang, Han
Ba, Yi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[5] Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
Mélanie Dos Santos
Justine Lequesne
Alexandra Leconte
Stéphane Corbinais
Aurélie Parzy
Jean-Marc Guilloit
Sharmini Varatharajah
Pierre-Emmanuel Brachet
Marine Dorbeau
Dominique Vaur
Louis-Bastien Weiswald
Laurent Poulain
Corentin Le Gallic
Marie Castera-Tellier
Marie-Pierre Galais
Bénédicte Clarisse
[J]. BMC Cancer, 22
[6] Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
Dos Santos, Melanie
Lequesne, Justine
Leconte, Alexandra
Corbinais, Stephane
Parzy, Aurelie
Guilloit, Jean-Marc
Varatharajah, Sharmini
Brachet, Pierre-Emmanuel
Dorbeau, Marine
Vaur, Dominique
Weiswald, Louis-Bastien
Poulain, Laurent
Le Gallic, Corentin
Castera-Tellier, Marie
Galais, Marie-Pierre
Clarisse, Benedicte
[J]. BMC CANCER, 2022, 22 (01)
[7] A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma
Sun, Weijing
Veeramachaneni, Nirmal
Al-Rajabi, Raed
Madan, Rashna
Kasi, Anup
Al-Kasspooles, Mazin
Baranda, Joaquina
Saeed, Anwaar
Phadnis, Milind A. A.
Godwin, Andrew K. K.
Olyaee, Mojtaba
Streeter, Natalie
Nagji, Alykhan
Dai, Junqiang
Williamson, Stephen
[J]. CANCER MEDICINE, 2023, 12 (15): : 16098 - 16107
[8] Phase I/II trial of perioperative avelumab in combination with chemoradiation (CRT) in the treatment of stage II/III resectable esophageal and gastroesophageal junction (E/GEJ) cancer.
Uboha, Nataliya Volodymyrivna
Eickhoff, Jens C.
Maloney, James D.
McCarthy, Daniel
DeCamp, Malcolm
Deming, Dustin A.
LoConte, Noelle K.
Matkowskyj, Kristina A.
Patel, Monica Arun
Hurst, Newton
Kratz, Jeremy D.
Lubner, Sam Joseph
Bassetti, Michael Frederick
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[9] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
Li, N.
Li, Z.
Fu, Q.
Zhang, B.
Zhang, J.
Wan, X.
Lu, C.
Wang, J.
Deng, W.
Wei, C.
Ma, Y.
Bie, L.
Wang, M.
Luo, S.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S1302 - S1302
[10] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
Li Ning
Li Zhi
Fu Qiang
Zhang Bin
Zhang Jian
Wan XiangBin
Lu Chaomin
Wang Jinbang
Deng Wenying
Wei Chen
Ma Yijie
Bie Liangyu
Wang Mengyu
Luo Suxia
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)

← 1 2 3 4 5 →